[
    [
        {
            "time": "2021-02-03",
            "original_text": "心通医疗-B公开发售获认购超769倍 每股发售价12.2港元",
            "features": {
                "keywords": [
                    "心通医疗-B",
                    "公开发售",
                    "认购",
                    "769倍",
                    "12.2港元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "心通医疗-B公开发售获认购超769倍 每股发售价12.2港元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-03",
            "original_text": "多家上市药企报喜拟中标药品集采，集采常态化医药板块如何走？",
            "features": {
                "keywords": [
                    "上市药企",
                    "药品集采",
                    "集采常态化",
                    "医药板块"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "多家上市药企报喜拟中标药品集采，集采常态化医药板块如何走？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-03",
            "original_text": "最高降幅95%！第四批药品带量采购竞标新出炉",
            "features": {
                "keywords": [
                    "药品带量采购",
                    "最高降幅",
                    "95%",
                    "第四批"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "最高降幅95%！第四批药品带量采购竞标新出炉",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-03",
            "original_text": "复星医药(02196)完成发行16亿元公司债 票面利率为3.98%",
            "features": {
                "keywords": [
                    "复星医药",
                    "公司债",
                    "16亿元",
                    "票面利率",
                    "3.98%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "复星医药(02196)完成发行16亿元公司债 票面利率为3.98%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-03",
            "original_text": "三大指数弱势震荡沪指跌0.46%，科技股大幅跳水，北向资金净买入34亿",
            "features": {
                "keywords": [
                    "三大指数",
                    "弱势震荡",
                    "沪指",
                    "科技股",
                    "北向资金",
                    "净买入",
                    "34亿"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "三大指数弱势震荡沪指跌0.46%，科技股大幅跳水，北向资金净买入34亿",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-03",
            "original_text": "第四轮国家药品集采：复星医药子公司中标索拉非尼",
            "features": {
                "keywords": [
                    "国家药品集采",
                    "复星医药",
                    "子公司",
                    "中标",
                    "索拉非尼"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "第四轮国家药品集采：复星医药子公司中标索拉非尼",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-03",
            "original_text": "第四批集采结果将在5月执行 机构看好这些药企",
            "features": {
                "keywords": [
                    "第四批集采",
                    "5月执行",
                    "机构看好",
                    "药企"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "第四批集采结果将在5月执行 机构看好这些药企",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]